Delivery Order SPE2DB20D1109-SPE2DB24FP27S
- Not listed
- This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA). The $2,016.85 firm-fixed price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract has an ultimate completion date of August 1, 2022. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC covers a broad range...
- This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA), a defense agency. The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 3, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
- This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML insulin pens to the Defense Logistics Agency (DLA). The $1,980.20 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 9, 2024. The contract has an ultimate completion date of December 10, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is an order for Lantus Solostar insulin pens placed by the Defense Logistics Agency (DLA) with AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,374.40 firm-fixed-price delivery order is for a one-time supply of the product, with a completion date of September 26, 2022. The contract was awarded on September 23, 2022 and does not have any set-aside designation. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Lantus Solostar insulin pens to the Defense Logistics Agency (DLA). The $1,469.00 firm fixed-price delivery order was issued to the prime contractor, AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order under AmerisourceBergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products...
- This federal contract award is for the delivery of Lantus Solostar insulin, a specialty medication for diabetes management, to the Defense Logistics Agency (DLA). The $1,380.84 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on December 2, 2024, with a performance period through December 3, 2024. This award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML, an insulin medication, to the Defense Logistics Agency (DLA). The $1,066.41 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on February 28, 2025. The contract has an ultimate completion date of March 3, 2025 and is not designated with a set-aside requirement. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Lantus Solostar insulin products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor, which received a $7,123.20 firm fixed-price delivery order under its $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The award has no set-aside designation, indicating full and open competition. This IDC serves as the primary vehicle for...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 12, 2025, with a completion date of February 13, 2025. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC)...
- This federal contract award is for the delivery of Lantus SoloStar 100 unit/ml 3ml insulin products to the U.S. Defense Logistics Agency (DLA). The $2,735.86 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB24FP27SDelivery Order
This federal contract award is for the delivery of Lantus Solostar insulin injections to the Defense Logistics Agency (DLA). The $2,767.60 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on June 3, 2024, with a completion date of June 4, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 6/3/24 |